343 related articles for article (PubMed ID: 23979750)
21. Prevalence of plasmid-mediated resistance genes among multidrug-resistant uropathogens in Egypt.
Elshamy AA; Aboshanab KM; Yassien MA; Hassouna NA
Afr Health Sci; 2020 Mar; 20(1):190-198. PubMed ID: 33402907
[TBL] [Abstract][Full Text] [Related]
22. Bacteremia in febrile cancer patients in Uganda.
Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
[TBL] [Abstract][Full Text] [Related]
23. New trends in pharmacogenomic strategies against resistance development in microbial infections.
Ohlsen K; Dandekar G; Schwarz R; Dandekar T
Pharmacogenomics; 2008 Nov; 9(11):1711-23. PubMed ID: 19018725
[TBL] [Abstract][Full Text] [Related]
24. [Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2006].
Yamaguchi K; Ishii Y; Iwata M; Watanabe N; Uehara N; Yasujima M; Kasai T; Suwabe A; Yamahata K; Kaku M; Kanemitsu K; Imafuku Y; Nishiyama K; Murakami M; Yomoda S; Taniguchi N; Yamada T; Nomura F; Watanabe M; Kanno H; Aihara M; Maesaki S; Hashikita G; Kondo S; Misawa S; Horiuchi H; Tazawa Y; Nakashima H; Takemura H; Okada M; Yamazaki F; Horii T; Maekawa M; Baba H; Ishigo S; Fujita N; Komori T; Ichiyama S; Iinuma Y; Maeda S; Yamanaka K; Murata Y; Matsuo S; Kohno H; Kinoshita S; Fujita J; Negayama K; Murase M; Miyamoto H; Kusano N; Mihara E; Itaha H; Ono J; Yoshimura H; Yanagihara K; Matsuda J; Saikawa T; Hiramatsu K
Jpn J Antibiot; 2007 Dec; 60(6):344-77. PubMed ID: 18447206
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
[TBL] [Abstract][Full Text] [Related]
26. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
[TBL] [Abstract][Full Text] [Related]
27. Eravacycline for the treatment of intra-abdominal infections.
Bassetti M; Righi E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1575-84. PubMed ID: 25251475
[TBL] [Abstract][Full Text] [Related]
28. Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals.
Iregui A; Landman D; Quale J
Microb Drug Resist; 2021 Feb; 27(2):190-195. PubMed ID: 32580619
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic resistance patterns of Gram-negative and Gram-positive strains isolated from inpatients with nosocomial infections in a tertiary hospital in Beijing, China from 2011 to 2014.
Zhu X; Tong A; Wang D; Sun H; Chen L; Dong M
J Chemother; 2017 Oct; 29(5):317-320. PubMed ID: 27347770
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016.
Dowzicky MJ; Chmelařová E
J Glob Antimicrob Resist; 2019 Jun; 17():44-52. PubMed ID: 30445209
[TBL] [Abstract][Full Text] [Related]
33. Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype.
Johnson JR; Porter SB; Johnston BD; Thuras P
Antimicrob Agents Chemother; 2015 Dec; 60(3):1888-91. PubMed ID: 26666925
[TBL] [Abstract][Full Text] [Related]
34. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Casellas JM
Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
[TBL] [Abstract][Full Text] [Related]
35. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Huband MD; Pfaller MA; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
[TBL] [Abstract][Full Text] [Related]
36. Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections.
Yang Q; Zhang H; Cheng J; Xu Z; Hou X; Xu Y
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):269-74. PubMed ID: 25641126
[TBL] [Abstract][Full Text] [Related]
37. Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control.
Reale M; Strazzulla A; Quirino A; Rizzo C; Marano V; Postorino MC; Mazzitelli M; Greco G; Pisani V; Costa C; Cesana BM; Liberto MC; Torti C; Focà A
Infez Med; 2017 Jun; 25(2):98-107. PubMed ID: 28603227
[TBL] [Abstract][Full Text] [Related]
38. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
[TBL] [Abstract][Full Text] [Related]
39. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
Kunz AN; Brook I
Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon.
Matta R; Hallit S; Hallit R; Bawab W; Rogues AM; Salameh P
J Infect Public Health; 2018; 11(3):405-411. PubMed ID: 28970096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
